This study not only provides the molecular insight into the nuclear IKKα-mediated maspin suppression in response to HBx, but also highlights the possibility of IKKα-targeting therapy in the treatment of HCC patients. The gene discussed is SERPINB5; the disease is hepatocellular carcinoma.